The role of serine/threonine kinases in T-cell activation

Current Opinion in Immunology

Volumn 18, Issue 3, 2006, Pages 314-320

  Matthews, Sharon A ^a   Cantrell, Doreen A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DIACYLGLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE D; PROTEIN SERINE THREONINE KINASE;

CELL MATURATION; CHROMATIN; ENZYME REGULATION; ENZYME SUBSTRATE; GENE CONTROL; GENETIC EPIGENESIS; LYMPHOCYTE; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33646148511     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.03.006     Document Type: Review

References (54)

1. Birnbaum M.J. Activating AMP-activated protein kinase without AMP. Mol Cell 19 (2005) 289-290. In this article, three recent studies that make a link between calcium signalling and AMPK are reviewed. The activation of AMPK requires the phosphorylation of Thr172 in the catalytic domain of AMPK. One well-established AMPK Thr172 kinase is LKB1 - the kinase mutated in Peutz-Jeghers syndrome. However, there is residual AMPK activity in LKB1-null cells that is mediated by calcium-induced activation of CaMKKs; CaMKKs act by directly phosphorylating AMPK on Thr172, thereby activating the enzyme. A novel link between calcium signals and the regulation of energy metabolism would clearly have an important role during immune cell stimulation.
2. Spitaler M., and Cantrell D.A. Protein kinase C and beyond. Nat Immunol 5 (2004) 785-790
3. Thuille N., Heit I., Fresser F., Krumbock N., Bauer B., Leuthaeusser S., Dammeier S., Graham C., Copeland T.D., Shaw S., et al. Critical role of novel Thr-219 autophosphorylation for the cellular function of PKCθ in T lymphocytes. EMBO J 24 (2005) 3869-3880. In this study, Thuille et al. demonstrate an important role for the PKCθ Thr219 autophosphorylation site in regulation of the correct targeting and cellular function of PKCθ during TCR ligation.
4. Balendran A., Hare G.R., Kieloch A., Williams M.R., and Alessi D.R. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484 (2000) 217-223
5. Benes C.H., Wu N., Elia A.E., Dharia T., Cantley L.C., and Soltoff S.P. The C2 domain of PKCδ is a phosphotyrosine binding domain. Cell 121 (2005) 271-280. This is the first description of a phosphotyrosine-binding motif within a serine/threonine kinase. Significantly, this suggests a potentially important role for the PKCδ C2 domain (and perhaps for the C2 domains of other novel PKCs) in regulating the assembly of phosphotyrosine-mediated protein-protein interactions during immune cell stimulation. Identification of tyrosine-phosphorylated proteins that interact with this novel signaling domain must be considered a priority for the future.
6. Tan S.L., and Parker P.J. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J 376 (2003) 545-552
7. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling. Nature 431 (2004) 456-461. Mecklenbrauker et al. demonstrate that B cell death correlates with the phosphorylation of nuclear histone H2B by nuclear-localised PKCδ,whereas BAFF, a potent B cell survival factor, prevents both the nuclear accumulation of PKCδ and H2B phosphorylation. Dysregulation of this novel survival pathway in PKCδ-deficiency thus renders B cells BAFF-independent, which accounts for the enhanced B cell survival observed in these mice.
8. Monks C.R., Kupfer H., Tamir I., Barlow A., and Kupfer A. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385 (1997) 83-86
9. Lynch O.T., and Gadina M. Ubiquitination for activation: new directions in the NF-κB roadmap. Mol Interv 4 (2004) 144-146
10. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 4 (2004) 348-359
11. ••] provide compelling evidence of the molecular mechanisms by which PKCβ and PKCθ use CARMA phosphorylation to regulate the IKK-NFκB pathway in B and T lymphocytes. See main body of text and Figure 1 for details.
12. ••].
13. ••].
14. Beinke S., and Ley S.C. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem J 382 (2004) 393-409
15. Rozengurt E., Rey O., and Waldron R.T. Protein kinase D signaling. J Biol Chem 280 (2005) 13205-13208
16. Hausser A., Storz P., Martens S., Link G., Toker A., and Pfizenmaier K. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex. Nat Cell Biol 7 (2005) 880-886
17. Matthews S.A., Iglesias T., Rozengurt E., and Cantrell D. Spatial and temporal regulation of protein kinase D (PKD). EMBO J 19 (2000) 2935-2945
18. Marklund U., Lightfoot K., and Cantrell D. Intracellular location and cell context-dependent function of protein kinase D. Immunity 19 (2003) 491-501
19. Medeiros R.B., Dickey D.M., Chung H., Quale A.C., Nagarajan L.R., Billadeau D.D., and Shimizu Y. Protein kinase D1 and the β1 integrin cytoplasmic domain control β1 integrin function via regulation of Rap1 activation. Immunity 23 (2005) 213-226
20. Parra M., Kasler H., McKinsey T.A., Olson E.N., and Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 280 (2005) 13762-13770
21. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., and McKinsey T.A. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24 (2004) 8374-8385
22. Dequiedt F., Van Lint J., Lecomte E., Van Duppen V., Seufferlein T., Vandenheede J.R., Wattiez R., and Kettmann R. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med 201 (2005) 793-804
23. Matthews S.A., Liu P., Spitaler M., Olson E.N., McKinsey T.A., Cantrell D.A., and Scharenberg A.M. An essential role for PKD family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Biol Cell 26 (2006) 1569-1577. This report demonstrates a novel link between the B cell antigen receptor, PKD enzymes and the regulation of class II HDACs. Using gene targeting technology in the DT40 system, B cell lines lacking PKD1, PKD3 or both of these isoforms were generated. Loss of either PKD1 or PKD3 had no impact on HDAC phosphorylation whereas loss of both PKD1 and PKD3 abrogated B-cell receptor-induced HDAC phosphorylation and nuclear export. These studies reveal an essential and redundant role for PKD enzymes in control of class II HDACs in B lymphocytes and suggest that PKD serine kinases might play a crucial role the control of gene expression.
24. Webb L.M., Vigorito E., Wymann M.P., Hirsch E., and Turner M. Cutting edge: T cell development requires the combined activities of the p110γ and p110δ catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 175 (2005) 2783-2787
25. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., Pearce W., Meek S.E., Salpekar A., Waterfield M.D., et al. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297 (2002) 1031-1034
26. Brennan P., Babbage J.W., Burgering B.M., Groner B., Reif K., and Cantrell D.A. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7 (1997) 679-689
27. Edinger A.L., and Thompson C.B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 13 (2002) 2276-2288
28. Burgering B.M., and Medema R.H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 73 (2003) 689-701
29. Mora A., Komander D., van Aalten D.M., and Alessi D.R. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15 (2004) 161-170
30. Sonnenburg E.D., Gao T., and Newton A.C. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 276 (2001) 45289-45297
31. McManus E.J., Collins B.J., Ashby P.R., Prescott A.R., Murray-Tait V., Armit L.J., Arthur J.S., and Alessi D.R. The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation. EMBO J 23 (2004) 2071-2082
32. Lawlor M.A., Mora A., Ashby P.R., Williams M.R., Murray-Tait V., Malone L., Prescott A.R., Lucocq J.M., and Alessi D.R. Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21 (2002) 3728-3738
33. •].
34. •]
35. Astoul E., Laurence A.D., Totty N., Beer S., Alexander D.R., and Cantrell D.A. Approaches to define antigen receptor-induced serine kinase signal transduction pathways. J Biol Chem 278 (2003) 9267-9275
36. Fox C.J., Hammerman P.S., and Thompson C.B. The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201 (2005) 259-266. Cell growth and survival is, in part, mediated by the mTOR pathway, however T cells are refractory to the mTOR inhibitor rapamycin. In this study, Thompson and co-workers have determined that T cell activation leads to the rapamycin-resistant transcriptional up-regulation of the PIM1/2 kinases. T cells that lack these PIM kinases are sensitive to rapamycin. Thus, the T cell antigen receptor signals independently to two redundant pathways that control T cell growth and survivial: first, a rapamycin-sensitive mTOR pathway and, second, a rapamycin-independent pathway regulated by PIM kinases. The presence of two functionally overlapping signaling cascades underscores the vital importance of this pathway for normal immune responses in vivo.
37. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., and Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 (2002) 177-189
38. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14 (2004) 1296-1302
39. Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A., and Hall M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6 (2004) 1122-1128
40. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
41. Mack K.D., Von Goetz M., Lin M., Venegas M., Barnhart J., Lu Y., Lamar B., Stull R., Silvin C., Owings P., et al. Functional identification of kinases essential for T-cell activation through a genetic suppression screen. Immunol Lett 96 (2005) 129-145
42. Thuille N., Gruber T., Bock G., Leitges M., and Baier G. Protein kinase Cβ is dispensable for TCR-signaling. Mol Immunol 41 (2004) 385-390
43. + T cells. Immunol Lett 96 (2005) 291-293
44. Gruber T., Thuille N., Hermann-Kleiter N., Leitges M., and Baier G. Protein kinase Cε is dispensable for TCR/CD3-signaling. Mol Immunol 42 (2005) 305-310
45. Berg-Brown N.N., Gronski M.A., Jones R.G., Elford A.R., Deenick E.K., Odermatt B., Littman D.R., and Ohashi P.S. PKCθ signals activation versus tolerance in vivo. J Exp Med 199 (2004) 743-752. Although PKCθ-deficient T cells are hypo-responsive to peptide stimulation in vitro and in vivo, these two groups clearly demonstrate that anti-viral cytotoxic T lymphocyte responses in PKCθ-knockout mice are normal. It appears that additional signals from the innate immune system can compensate for the loss of PKCθ in T cells during pathogenic infections. Thus, PKCθ is not a crucial signalling molecule required for global T-mediated cell immune responses, as was previously thought.
46. ••].
47. Giannoni F., Lyon A.B., Wareing M.D., Dias P.B., and Sarawar S.R. Protein kinase C θ is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68. J Virol 79 (2005) 6808-6813
48. •] both show that PKCθ is dispensable for Th1-mediated immune responses but is important for Th2 cell differentiation and function. However, purified naïve PKCθ-deficient T cells show enhanced IFNγ production during T cell activation, suggesting that PKCθ might well control some aspect of Th1 cell function. In this context, PKCθ regulates Th1 cytokine production in a model of experimental autoimmune encephalomyelitis [50]. How and why PKCθ regulates Th1/2 cell differentiation and/or function is not known.
49. •].
50. Salek-Ardakani S., So T., Halteman B.S., Altman A., and Croft M. Protein kinase Cθ controls Th1 cells in experimental autoimmune encephalomyelitis. J Immunol 175 (2005) 7635-7641
51. + T cells. J Immunol 175 (2005) 5126-5134
52. Bandyopadhyay G., Standaert M.L., Sajan M.P., Kanoh Y., Miura A., Braun U., Kruse F., Leitges M., and Farese R.V. Protein kinase C-λ knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. Mol Endocrinol 18 (2004) 373-383
53. Martin P., Villares R., Rodriguez-Mascarenhas S., Zaballos A., Leitges M., Kovac J., Sizing I., Rennert P., Marquez G., Martinez A.C., et al. Control of T helper 2 cell function and allergic airway inflammation by PKCζ. Proc Natl Acad Sci USA 102 (2005) 9866-9871
54. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6 (2005) 1087-1095